ArticleJournal of thoracic disease2025
The impact of high-risk zip code on receiving standard of care therapy and survival in esophageal adenocarcinoma.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- ASO Author Reflections: Where You Live and Where You're Treated: Addressing Disparities in Esophageal Adenocarcinoma.Annals of surgical oncology · 2026Article
- Urban-rural disparities in survival of Chinese esophageal squamous cell carcinoma: a cohort study of 133,064 cases.BMC gastroenterology · 2026Article
- The Impact of Social Determinants of Health on Treatment Received in Patients with Stage I Lung Cancer in Ontario: A Population-Based Analysis.Current oncology (Toronto, Ont.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of sociodemographic disparities on oncologic outcomes has been established. The opportunity to investigate high-risk zip codes of residence as related to standard-of-care therapy and subsequent survival offers an avenue to mitigate disparities in esophageal cancer. We aim to evaluate the impact of zip code of residence on survival in those with esophageal adenocarcinoma (EAC). Methods: The National Cancer Database (NCDB) (2012-2021) was utilized to identify patients with non-metastatic EAC who received trimodal therapy. A "high-risk" zip code group was defined as those living in a zip code where >10.9% did not have a high school diploma or the median household income was <$50,353. Results: Of 10,520 patients, 25.01% resided in a high-risk zip code and 89.33% (n=9,398) received standard-of-care trimodal therapy. High-risk zip code was independently associated with reduced odds of receiving trimodal therapy [odds ratio (OR) 0.764, 95% confidence interval (CI): 0.59-0.99, P=0.047] and persisted as an independent negative prognostic factor for survival [hazard ratio (HR) 1.189, 95% CI: 1.09-1.29, P=0.001] in those that received CROSS-concordant therapy. A reduction in median survival was observed in the high-risk zip code group (38.41 months, 95% CI: 35.98-43.24) compared to the low-risk zip code group (44.65 months, 95% CI: 42.15-47.15). Similarly, 5-year overall survival (OS) was reduced in the high-risk group at 39.12% versus 43.31% in the low-risk group (P=0.001). Conclusions: A less affluent and educated zip code of residence is associated with a significant reduction in odds of receiving standard-of-care treatment in EAC. In those receiving trimodal therapy, zip code is a negative prognosticator with associated survival reductions. Identification of at-risk patients and interventions to mitigate such disparities is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.